GlassScriptPhysician profile
Gloria J Stevens
NPI 1699836288
$23,193.49
in general payments reported to CMS, 2019-2025
45 companies · $3,471 in 2025
The $3,471 reported for 2025 was more than what 86% of Procedural Dermatology providers received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,887 · 2020: $1,169 · 2021: $2,198 · 2022: $3,587 · 2023: $3,943 · 2024: $3,938 · 2025: $3,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,180.05 |
| Education | $171.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,739.50 | 2019-2025 | Skyrizi, Rinvoq |
| Galderma Laboratories, L.P. | $1,649.72 | 2019-2025 | Nemluvio, Aklief, Epsolay |
| Pfizer INC. | $1,516.92 | 2019-2025 | |
| Genzyme Corporation | $1,474.53 | 2019-2025 | |
| Leo Pharma INC. | $1,456.09 | 2019-2025 | Adbry, Anzupgo |
| Amgen INC. | $1,206.59 | 2020-2025 | Otezla, Otezla |
| Lilly USA, LLC | $933.37 | 2020-2025 | Olumiant, Ebglyss, Taltz |
| E.R. Squibb & Sons, L.L.C. | $788.77 | 2022-2025 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $787.45 | 2019-2025 | Libtayo, Dupixent |
| Dermavant Sciences, INC. | $759.81 | 2022-2024 | Vtama |
| Mayne Pharma Commercial LLC | $745.72 | 2019-2025 | |
| Epi Health, LLC | $737.14 | 2020-2022 | |
| Journey Medical Corporation | $709.41 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $685.49 | 2023-2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $680.19 | 2019-2025 | Winlevi, Absorica Ld, Ilumya |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gloria Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.